QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 内容类型：会议论文    专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A Retrospective Analysis of Outcomes of Diffuse Large B Cell Lymphoma (DLBCL) in the Elder Patients in China 会议论文 BLOOD, 2018-11-29 作者:  Liu, Peng;  Han, Ying;  Yang, Jianliang;  He, Xiaohui;  Zhang, Changgong 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文 LABORATORY INVESTIGATION, 2018-03-01 作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng 收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03 First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文 ANNALS OF ONCOLOGY, 2018-11-01 作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Quality-of-life and health utility scores for common cancers in China: a multicentre cross-sectional survey 会议论文 LANCET, 2016-10-01 作者:  Shi, Ju-Fang;  Huang, Hui-Yao;  Guo, Lan-Wei;  Shi, Dian;  Gu, Xiu-Ying 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE). 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Shi, Yuankai;  Wang, Lin;  Han, Baohui;  Li, Wei;  Yu, Ping 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Phase I clinical pharmacokinetics, safety and tolerability of simotinib in advanced NSCLC patients with EGFR mutation 会议论文 EUROPEAN JOURNAL OF CANCER, 2015-09-01 作者:  Han, X.;  Li, N.;  Hu, X.;  Song, Y.;  Zhang, Y. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 Clinical pharmacokinetics of simotinib, an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC patients. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20 作者:  Han, Xiaohong;  Li, Ning;  Hu, Xingsheng;  Song, Yuanyuan;  Zhang, Yan 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/13 Identification of genetic alterations in Chinese squamous cell lung carcinomas 会议论文 EUROPEAN JOURNAL OF CANCER, 2015-09-01 作者:  Shi, Y.;  Tao, D.;  Han, X.;  Yang, S.;  Wu, D. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: Pharmacokinetics, toxicity, and preliminary efficacy. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20 作者:  Shi, Yuankai;  Yang, Jianliang;  Gui, Lin;  Liu, Peng;  Han, Xiaohong 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Pre-planned Subgroup Analyses From the Phase III, Randomised, Placebo-controlled, Parallel-group Study of Gefitinib (G) as Maintenance Therapy in Patients (pts) With Locally Advanced or Metastatic Non-small-cell Lung Cancer (NSCLC) (INFORM; C-TON 会议论文 EUROPEAN JOURNAL OF CANCER, 2011-09-01 作者:  Zhang, L.;  Ma, S. L.;  Song, X. Q.;  Cheng, Y.;  Huang, C. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13